Collin M. Blakely Department of Medicine University of California, San Francisco Biography Publications Institution JoVE Articles Collin M. Blakely has not added a biography. If you are Collin M. Blakely and would like to personalize this page please email our Author Liaison for assistance. Publications Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing Cell. 09, 2020 | Pubmed ID: 32822576 Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 01, 2020 | Pubmed ID: 31548343 A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 12, 2019 | Pubmed ID: 31611281 Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation Clinical Lung Cancer. 03, 2019 | Pubmed ID: 30553716 Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids Dora Barbosa Rabago1,2,3, Collin M. Blakely1,2, Franziska Haderk1,2,3, Trever G. Bivona1,2,3 1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco JoVE 63039 Cancer Research
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids Dora Barbosa Rabago1,2,3, Collin M. Blakely1,2, Franziska Haderk1,2,3, Trever G. Bivona1,2,3 1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco JoVE 63039 Cancer Research
